IV
Innovent Biologics, Inc.
IVBXF · OTC
$12.36 +12.27% (+$1.35)
1M +4.75%
Market Cap ¥144.0B
P/E Ratio 181.74x
Div. Yield -
ROE 4.69%
Bulios Fair Price
$9.18
25.7% downside
Trenutna cena
$12.36
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica IVBXF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
25 /100
Expensive P/S 11.34x
P/E 181.74x
P/B 7.44x
Growth
100 /100
Growing Book val. growth 21.75%
Rev. growth 40.75%
FCF growth N/A
Profitability
79 /100
Strong Op. margin 15.50%
Gross margin 86.54%
FCF margin 73.34%
Quality
27 /100
Poor ROA 2.12%
ROIC 6.59%
Asset turnover 0.34x
Debt
100 /100
Low Int. coverage 25.40x
Debt/Equity 0.15x
Net debt/EBITDA -7.38x
Stability
34 /100
Moderate EPS volatility 486.75%
Beta 0.24x
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IVBXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
De-Chao Yu
Employees
7,502
Headquarters
Suzhou
Prihajajoči dogodki
31 MAR.
Earnings
Upcoming earnings report